Kidney 2025 | On Demand Conference

Learn from the leading nephrology and internal medicine experts from across Canada to explore the future of kidney care through the lens of innovation, evidence, and clinical practicality.
  • View Learning Objectives
  • View Full List of Faculty

Key Topics by Session

Session 1
Session 2
Session 3
Session 4
Session 5

Session 1 Topics:

  • PLENARY 1: How I Use AI and How It Has Changed My Practice
    with Jordan Weinstein
  • Q&A

Meet the Faculty:

Jordan J. Weinstein

MD, FRCPC
University of Toronto, Toronto, ON

Session 2 Topics:

  • Inflammation in Atherosclerosis and CKD Monoclonal with Subodh Verma
  • Antibodies – A Brave New Future for Cardiorenal Metabolic Diseases with Anique Ducharme
  • Non-steroidal MRAs – Protecting the Kidneys and the Heart with Subodh Verma
  • PCSK9 Inhibition in People Living with CKD with(out) ASCVD with Priya Manjoo
  • IPE for Risk Reduction in CKD and DKD with Grace Chua
  • Q&A

Meet the Faculty:

Session 3 Topics:

  • A Prescription for Caution: Protecting the Kidneys from Harmful Medications
    with Jo-Anne Wilson
  • Nephrology Clinical Pearls for the Non-Nephrologist - A Case-Based Presentation with Andrew Steele
  • Q&A

Meet the Faculty:

Session 4 Topics:

  • GLP-1R-based Therapies for People Living with CKD and Obesity
    with Louise Moist
  • PLENARY 2: GLP-1R-based Therapies and Kidney Protection
    with David Cherney
  • Q&A

Meet the Faculty:

Session 5 Topics:

  • Vaccinations in High-Risk Individuals with CKD with Vivien Brown
  • Controversies in Onco-nephrology with Abhijat Kitchlu
  • IGA: A Pragmatic Approach in 2025 with Louis-Philippe Girard
  • Renal AMLs: What to Do and When to Dig Deeper with Andrew House
  • Q&A

Meet the Faculty

This educational initiative is developed by the Canadian Medical & Surgical Knowledge Translation Research Group (CMS).

This program has received education grants from:  Amgen Canada, Bayer Inc., Eli Lilly Canada, GSK Canada, HLS Therapeutics Inc., Janssen Pharmaceuticals, Novo Nordisk Canada Inc. and Otsuka Pharmaceuticals.

Start Learning

Share this program with your peers